Background:Holoptelea integrifolia and Parietaria judaica belong to the family Urticaceae, but are geographically distantly located. H. integrifolia is an important pollen allergen of India and sensitizes almost 10% of the atopic population in Delhi. P. judaica, on the other hand, is a very dominant pollen allergen of the Mediterranean region, sensitizing almost 80% of the allergic population. Since both these important pollen allergens belong to the family Urticaceae, the objective of the present study was to assess cross-reactivity between these two pollen allergens from different geographical regions. Methods: Cross-reactivity between these two pollen allergens was assessed on the basis of skin prick tests and ELISA, ELISA inhibition and immunoblot inhibition studies. Results: Out of 44 atopic Indian patients skin prick tested with H. integrifolia extract, 34% were found to be sensitized. All the patients sensitized to H. integrifolia also showed varying degrees of skin positivity to P. judaica pollen extract. ELISA and ELISA inhibition studies suggested strong cross-reactivity between H. integrifolia and P. judaica pollen. Immunoblot inhibition studies revealed that 14-, 16-, 28-, 38-, 42- and 46-kDa proteins are the cross-reactive proteins in H. integrifolia and P. judaica. However, Par j 1, the major allergen of P. judaica, is absent in H. integrifolia pollen. Conclusion:H. integrifolia and P. judaica pollens share cross-reactive as well as unique epitopes. The major allergen of P. judaica, Par j 1, seems to be absent in H. integrifolia pollen allergen.

1.
Singh AB, Singh A: Pollen allergy – A global scenario; in Agashe SN (ed): Recent Trends in Aerobiology, Allergy and Immunology. New Delhi, Oxford & IBH Publishing, 1994, pp143–170.
2.
Palosuo T, Panzani RC, Singh AB, Ariano R, Alenius H, Turjanmaa K: Allergen cross-reactivity between proteins of the latex from Hevea brasiliensis, seeds and pollen of Ricinus communis, and pollen of Mercurialis annua, members of the Euphorbiaceae family. Allergy Asthma Proc 2002;23:141–147.
3.
Sriramarao P, Rao PVS: Allergenic cross-reactivity between Parthenium and ragweed pollen allergens. Int Arch Allergy Immunol 1993;100:79–85.
4.
Stumvoll S, Westritschnig K, Lidholm J, Spitzauer S, Colombo P, Duro G, Kraft D, Geraci D, Valenta R: Identification of cross-reactive and genuine Parietaria judaica pollen allergens. J Allergy Clin Immunol 2003;111:974–999.
5.
Corbi AL, Pelaez A, Errigo E, Carreira J: Cross-reactivity between Parietaria judaica and Parietaria officinalis. Ann Allergy 1985;54:142–147.
6.
Corbi AL, Cortes C, Bousquet J, Basomba A, Cistero A, Garcia-Selles J, D’Amato G, Carreira J: Allergenic cross-reactivity among pollens of Urticaceae. Int Arch Allergy Appl Immunol 1985;77:377–383.
7.
Bousquet J, Hewitt B, Guerin B, Dhivert H, Michel FB: Allergy in the Mediterranean area. 2. Cross-allergenicity among Urticaceae pollens (Parietaria and Urtica). Clin Allergy 1986;16:57–64.
8.
Miura N: Ramie (Boehmeria nivea) pollen-induced bronchial asthma and allergenic cross-reactivity of ramie and Parietaria. Arerugi 1993;42:649–655.
9.
Agnihotri MS, Singh AB: Observations on pollinosis in Lucknow with special reference to offending factors. Asp Allergy Appl Immunol 1971;5:135–141.
10.
Anonymous: All India Coordinated Project on Aeroallergens and Human Health. Final technical report. Ministry of Environment and Forest, Govt of India, New Delhi, 2000.
11.
D’Amato G, Ruffilli A, Ortolani C: Allergenic significance of Parietaria (Pellitory-of-the-wall) pollen; in D’Amato G, Spieksma FT, Bonnini S (eds): Allergenic Pollen and Pollinosis in Europe. Oxford, Blackwell Scientific Publications, 1991, pp 113–118.
12.
Anonymous: The Wealth of India – Raw materials. CSIR, New Delhi. Eds Shastri BN 1991, pp 109–110.
13.
Singh AB, Kumar P: Aeroallergens in clinical practice of allergy in India. An overview. Ann Agric Environ Med 2003;10:131–136.
14.
Malik P, Singh AB, Gangal SV, Babu CR: Comparison of antigenic and allergenic components of Holoptelea integrifolia pollen collected from different source materials. Allergy 1991;46:284–291.
15.
Ayuso R, Polo F, Carreira J: Purification of Par j 1, the major allergen of Parietaria judaica pollen. Mol Immunol 1988;25:49–56.
16.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
17.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
18.
Singh AB, Malik P, Prakash D, Gupta CK: Biological standardization of pollen allergens from India. Asian Pac J Allergy Immunol 1992;10:103–109.
19.
Sepulveda R, Longbottom JL, Pepys J: Enzyme linked immunosorbent assay (ELISA) for IgG and IgE antibodies to protein and polysaccharide antigens of Aspergillus fumigatus. Clin Allergy 1979;9:359–371.
20.
Calenoff E, McMahan JT, Herzon GD, Kern RC, Ghadge GD, Hanson DG: Bacterial allergy in nasal polyposis. A new method for quantifying specific IgE. Arch Otolaryngol Head Neck Surg 1993;119:830–836.
21.
Ayuso R, Carreira J, Polo F: Quantification of the major allergen of several Parietaria pollen by an anti Par j 1 monoclonal antibody based ELISA. Analysis of cross-reactivity among purified Par j 1, Par o 1 and Par m 1 allergens. Clin Exp Allergy 1995;25:993–999.
22.
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350–4354.
23.
Barletta B, Afferni C, Tinghino R, Mari A, Di Felice G, Pini C: Cross-reactivity between Cupressus arizonica and Cupressus sempervirens pollen extracts. J Allergy Clin Immunol 1996;98:797–804.
24.
Halmepuro L, Vuontela K, Kalimo K, Björkstèn F: Cross-reactivity of IgE antibodies with allergens in birch pollen, fruits and vegetables. Int Arch Allergy Appl Immunol 1984;74:235–240.
25.
Garcia-Selles FJ, Diaz-Perales A, Sanchez-Monge R, Alcantara M, Lombardero M, Barber D, Salcedo G, Fernandez-Rivas M: Patterns of reactivity to lipid transfer proteins of plant foods and Artemisia pollen: An in vivo study. Int Arch Allergy Immunol 2002;128:115–122.
26.
Ford SA, Baldo BA, Geraci D, Bass D: Identification of Parietaria judaica pollen allergens. Int Arch Allergy Appl Immunol 1986;79:120–126.
27.
Scheurer S, Pastorello EA, Wangorsch A, Kästner M, Haustein D, Vieths S: Recombinant allergens Pru av 1 and Pru av 4 and a newly identified lipid transfer protein in the in vitro diagnosis of cherry allergy. J Allergy Clin Immunol 2001;107:724–731.
28.
Ballmer-Weber BK, Scheurer S, Fritsche P, Enrique E, Cistero-Bahima A, Haase T, Wuthrich B: Component-resolved diagnosis with recombinant allergens in patients with cherry allergy. J Allergy Clin Immunol 2002;110:167–173.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.